C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof

Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008)
12/2002
12/05/2002	US20020183385 Administering a therapeutically effective amount of arsenic compounds to a mammal for treating solid tumor
12/05/2002	US20020182625 Nucleotide sequence labelling compoumd four use as tool in genetic engineering
12/04/2002	EP1262564A2 Dna sequencing by mass spectrometry
12/04/2002	EP1261745A2 Nucleic acids, proteins, and antibodies
12/04/2002	EP1261703A1 Nucleic acids, proteins, and antibodies
12/04/2002	EP1261637A1 Nucleic acids, proteins, and antibodies
12/04/2002	EP1261634A1 Nucleic acids, proteins, and antibodies
12/04/2002	EP1261633A2 Nucleic acids, proteins, and antibodies
12/04/2002	EP1261618A2 Nucleic acids, proteins, and antibodies
12/04/2002	EP1261616A2 Modified oligonucleotides for mismatch discrimination
12/04/2002	EP1261380A1 Nucleic acids, proteins and antibodies
12/04/2002	EP1261350A1 METHODS FOR SYNTHESIZING 2-CHLORO-9-(2-DEOXY-2-FLUORO-$g(b)-D-ARABINOFURANOSYL)- i 9H /i -PURIN-6-AMINE
12/04/2002	EP1261323A2 Method of treating gastrointestinal tract disease with purinergic receptor agonists
12/04/2002	CN1383430A Process for prepn. of cytidine derivatives
12/04/2002	CN1383427A Process for preparing N6-substituted deaza-adenosine derivatives
12/04/2002	CN1383382A Use of methoxymorpholino dexorubicin for treatment of liver tumor
12/03/2002	US6489466 C-3′ protected monomeric nucleotides and synthesis of oligonucleotides on solid support
11/2002
11/28/2002	WO2002095073A1 Method for the synthesis of dna sequences
11/28/2002	WO2002094844A2 Antiviral nucleosides
11/28/2002	WO2002094289A1 Antiviral nucleoside derivatives
11/28/2002	WO2002094273A2 Combination of an adenosine a2a-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways
11/28/2002	WO2002094185A2 Conjugates and compositions for cellular delivery
11/28/2002	WO2002070532A3 C2,5'-disubstituted and n6,c2,5'-trisubstituted adenosine derivatives and their different uses
11/28/2002	WO2002036601A3 Phase transfer catalyzed glycosidation of an indolocarbazole
11/28/2002	US20020177703 Novel crystalline forms of an antiviral benzimidazole compound
11/28/2002	US20020177702 Generating preferential crystals of disodium 5'- guanylate and disodium 5'-inosinate; obtain mixed solution of disodium 5'-guanylate and disodium 5'- inosinate, heat, form slurry, recover crystals
11/28/2002	US20020177695 Nucleosides for use in the detection of preferential nucleotide sequences
11/28/2002	US20020177158 Detection of preferential protein in sample; obtain pool of proteins, incubate with probe, detect signal from probe, recover proteins
11/28/2002	US20020177137 Detecting preferential nucleotide sequences in pool of sequences; obtain nucleotide sequences, deposit on substrate, incubate with probe, detect signal, which indicates, presencec of preferential sequences
11/28/2002	CA2826505A1 Antiviral nucleosides
11/28/2002	CA2447240A1 Method for the synthesis of dna sequences
11/28/2002	CA2447161A1 Conjugates and compositions for cellular delivery
11/28/2002	CA2446620A1 Antiviral nucleosides
11/28/2002	CA2445789A1 Combination of an adenosine a2a-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways
11/27/2002	EP1260516A1 Method for producing a beta-D-ribofuranose derivative or an optical isomer thereof
11/27/2002	EP1259642A1 Nucleic acids, proteins, and antibodies
11/27/2002	EP1259540A1 Nucleic acids, proteins, and antibodies
11/27/2002	EP1259531A2 Nucleic acids, proteins, and antibodies
11/27/2002	EP1259526A2 Nucleic acids, proteins, and antibodies
11/27/2002	EP1259524A2 Nucleotides and polynucleotides immobilised on a solid support via a disulphide linkage
11/27/2002	EP1144430A4 Protecting groups for carbohydrate synthesis
11/27/2002	CN1382152A Novel A-500359 derivatives
11/26/2002	US6486313 Oligonucleotides having alkylphosphonate linkages and methods for their preparation
11/26/2002	US6486308 Covalently linked oligonucleotide minor groove binder conjugates
11/26/2002	US6486287 Such as n,n-bis(2-trimethoxysilylpropyl)ethanolamine; for silanation of surfaces such as glass and subsequent immobilization of nucleic acids and polypeptides
11/26/2002	US6486286 Use of hexahydrolupulones as antibacterial agents
11/26/2002	US6486195 Thermodynamically stable crystal form of 4″-deoxy-4″-epi-methylamino avermectin B1a/B1b benzoic acid salt and processes for its preparation
11/26/2002	US6485944 Replica amplification of nucleic acid arrays
11/26/2002	US6485941 Inhibition of the carboxyltransferase component of acetyl-CoA carboxylase, and the use of such inhibition in anti-cancer and anti-lipogenic therapies
11/26/2002	CA2103580C Orthomolecular method of treating sickle cell disease
11/26/2002	CA2095214C Agents for the treatment of diseases caused by parasitic protozoa and neoplastic diseases
11/26/2002	CA2067184C New linker for bioactive agents
11/21/2002	WO2002092766A2 Compositions and methods for separating heterocyclic aromatic amine bases, nucleosides, nucleotides, and nucleotide sequences
11/21/2002	WO2002092093A1 Adenosine analogues for the treatment of the insulin resistance syndrome and diabetes
11/21/2002	US20020173498 Topical administering; skin disorders
11/21/2002	US20020173474 Methods & materials involving dimerization-mediated regulation of biological events
11/21/2002	US20020173012 Process for the preparation of pharmaceutically acceptable salts of (R,S)-S-adenosyl-L-methionine
11/21/2002	US20020172962 Generation of nucleotide sequence ligands; obtain nucleotide sequences mixture, separate nucleotide sequences, amplify nucleotide sequences, incubate with modulator, detect adjustment in binding activity
11/21/2002	DE10120797A1 Verfahren zur Analyse von Nukleinsäureketten A process for the analysis of nucleic acid chains
11/21/2002	CA2447408A1 Adenosine analogues for the treatment of the insulin resistance syndrome and diabetes
11/20/2002	EP1258490A1 Process for preparing indolopyrrolocarbazole derivatives, intermediates therefor, and preparation process of the intermediates
11/20/2002	EP1258489A1 Method for purifying 5'-protected thymidines
11/20/2002	EP1258248A2 Tumor treatments comprising a fumagillol derivative and a further antineoplastic agent
11/20/2002	EP1258247A1 Adenosine analogues for the treatment of insulin resistance syndrome and diabetes
11/20/2002	EP1257281A1 Nucleoside analogs with carboxamidine modified monocyclic base
11/20/2002	CN1380299A Method for purifying 5'-protected 2'-deoxypurine nucleoside
11/19/2002	US6482939 Form vi 5,6-dichloro-2-(isopropylamino)-1-(β-l-ribofuranosyl)-1h-bezimimidazole
11/19/2002	US6482938 Compounds having energy transfer function and method for DNA base sequencing by using the same
11/19/2002	US6482932 Nucleoside triphosphates and their incorporation into oligonucleotides
11/19/2002	US6482845 Method for inhibiting interleukin-2 production using tricyclo compounds
11/19/2002	US6482805 AZT derivatives exhibiting spermicidal and anti-viral activity
11/19/2002	US6482594 Made by exposing nucleic acid candidate sequences having photoreactive groups to the target molecule, irradiating complexes formed to crosslink, and separating the crosslinked complexes and amplifying to give the ligands
11/19/2002	CA2066134C Complexes of polyadenylic acid with polyuridylic acid
11/18/2002	CA2381829A1 A method for tumor treatment with fumagillol derivatives
11/15/2002	CA2386285A1 Method for purifying 5' -protected thymidines and novel derivatives thereof
11/14/2002	WO2002090359A1 Glucuronide adduct as gaba ligand
11/14/2002	WO2002089581A1 Antimicrobial compounds and methods for their use
11/14/2002	WO2002018404A3 Nucleoside derivatives for the treatment of hepatitis c
11/14/2002	US20020168678 Separation of preferential nucleotide sequences in sample; obtain sample, incubate with cleavage enzyme, apply electric current, separate nucleotide squences, evaluate nucleotide sequence pattern
11/14/2002	CA2827671A1 Phosphorus-containing antimicrobial compounds and methods for their use
11/14/2002	CA2445381A1 Phosphorous containing antimicrobial compounds and methods for their use
11/13/2002	EP1256589A2 Oligomers containing modified pyrimidines
11/13/2002	EP1256588A1 Novel pyrazine derivatives or salts thereof, pharmaceutical compositions containing the derivatives or the salts and intermediates for the preparation of both
11/13/2002	EP1255864A1 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255817A1 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255778A2 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255777A1 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255776A1 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255768A2 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255767A2 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255766A2 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255764A1 Purine derivatives
11/13/2002	EP1001962B1 Production of avermectin compounds
11/13/2002	EP0845001B1 5'-substituted-ribofuranosyl benzimidazoles as antiviral agents
11/13/2002	EP0778898B1 Reduction of nonspecific hybridization by using novel base-pairing schemes
11/13/2002	CN1379781A Novel oligosaccharides, preparation method and pharmaceutical composition containing same
11/13/2002	CN1379037A Ibuprofen ribavirin ester and its preparing process and application
11/12/2002	US6479656 Phosphorylation process and catalyst
11/12/2002	US6479651 Modified oligonucleotides, their preparation and their use
11/12/2002	US6479500 Alleviating side effects caused by use of an anti-tumor agent comprising administering 5-chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1h,3h)-pyrimidin edione

1 ... 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 ... 201